title: Gabapentin for the treatment of tremor.
abstract: OBJECTIVE
  To review the use of the antiepileptic drug gabapentin for the treatment of various types of tremor.
  
  
  METHODS
  A search of biomedical literature was completed through MEDLINE and EMBASE (1993-May 2002) to identify all clinical trials pertaining to the use of gabapentin for the treatment of tremor in humans.
  
  
  RESULTS
  Outcome data from the few published studies have varied widely. Patient groups have been small, and conclusions have been based largely on subjective patient and investigator ratings.
  
  
  CONCLUSIONS
  A trial of gabapentin is warranted in patients who fail therapy with traditional agents. Improvement should be measured by a patient's perceived functional ability.
authors.affiliation: School of Pharmacy and Allied Health Professions, Creighton University, Omaha, NE 68178-0401, USA. faulkner@creighton.edu
authors.forename: Michele A
authors.initials: MA
authors.lastname: Faulkner
authors.forename: John M
authors.initials: JM
authors.lastname: Bertoni
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Lenz
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000588:Amines; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids; D000077206:Gabapentin; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D016896:Treatment Outcome; D014202:Tremor / Q000145:classification / Q000188:drug therapy* / Q000209:etiology; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin